Yahoo Web Search

Search results

1. • 

     Milwaukee police pursuit, driver arrested; drugs, 'ghost gun' found

     WITI via Yahoo News· 3 days ago

     Several bags were also recovered. One bag had multicolored and multi-shaped pills suspected to be...

2. • 

     Earnings call: Belite Bio highlights progress in key drug trials, Q1 financials By Investing.com

     Investing.com· 6 days ago

     Despite reporting increased research and development expenses and a net loss for the quarter, Belite...

3. • Precigen Reports First Quarter 2024 Financial Results and Business Updates

     Morningstar· 7 days ago

     – Pivotal Phase 2 study data of PRGN-2012 for the treatment of patients with recurrent respiratory papillomatosis to be presented at the 2024 ASCO Annual Meeting as a late-breaking oral presentation on June 3rd – – Company to host a conference

4. • Salzburg Intensive Care database (SICdb): a detailed exploration and comparative analysis with...

     Nature· 1 day ago

     The data in the SICdb have been anonymized in accordance with article 4(5) of the European General Data Protection Regulation (GDPR) 28. The database includes data exclusively from ICU patients ...

5. • Washington County Grand Jury

     The Marietta Times· 5 days ago

     The Washington County Grand Jury indicted 24 people this week on a variety of charges. The following indictments were issued: * Marcus Evan MacAuley, 18, Marietta, third-degree strangulation ...

6. • Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose...

     Morningstar· 6 days ago

     ALACHUA, Fla. and CHICAGO, May 14, 2024 /PRNewswire/ -- Nanopharmaceutics, Inc. (OTC:TGRP), a clinical-stage pharmaceutical development company, announced the initiation of a Phase I clinical study with the Robert H. Lurie Comprehensive Cancer Center

7. • 

     Carisma Therapeutics begins trial for novel cancer therapy By Investing.com

     Investing.com· 5 days ago

     Carisma Therapeutics Inc. (NASDAQ: CARM), a biopharmaceutical company, announced today the...

8. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 5 days ago

     Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell

9. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 5 days ago

     Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic ...

10. • CNS Pharmaceuticals Reports First Quarter 2024 Financial Results

      Morningstar· 5 days ago

      Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025Company committed to addressing the most aggressive type of brain cancer ...